Most practicing orthopaedic surgeons currently use a pharmacologic agent as a means of prophylaxis for deep venous thrombosis and pulmonary embolism following total hip arthroplasty, total knee ...
Recent studies have indicated a rising incidence of this disease in children over the years. Additionally, the pharmacological treatment of thrombotic diseases in children faces numerous challenges.
A number of risk factors have been associated with venous thromboembolism, such as age, previous history of DVT or PE ... and warfarin are used for pharmacologic prophylaxis.